Rupali Life Insurance Company Limited (DSE:RUPALILIFE)
Bangladesh · Delayed Price · Currency is BDT 87.70
-0.90 (-1.02%)
At close: Feb 10, 2026
DSE:RUPALILIFE Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Premiums & Annuity Revenue | 2,089 | 2,184 | 2,322 | 2,127 | 2,505 | 2,472 |
Total Interest & Dividend Income | 236.89 | 232.96 | 239 | 251.54 | 270.1 | 247.8 |
Gain (Loss) on Sale of Investments | 2.92 | 2.92 | 1.35 | 10.19 | 35.59 | 1.43 |
Other Revenue | 3.24 | 2.82 | 3.08 | 3.28 | 2.76 | 3.53 |
| 2,332 | 2,423 | 2,565 | 2,392 | 2,814 | 2,725 | |
Revenue Growth (YoY) | 1.27% | -5.56% | 7.25% | -14.99% | 3.27% | 3.88% |
Policy Benefits | 1,225 | 1,646 | 1,728 | 1,692 | 1,538 | 1,399 |
Policy Acquisition & Underwriting Costs | 388.88 | 410.01 | 451.22 | 457.96 | 610.23 | 644.83 |
Amortization of Goodwill & Intangibles | 0.23 | 0.23 | 0.29 | 0.36 | - | - |
Depreciation & Amortization | 23.72 | 23.72 | 25.36 | 29.64 | 31.22 | 33.69 |
Selling, General & Administrative | 126.54 | 121.9 | 146.83 | 147.28 | 148.15 | 128.61 |
Other Operating Expenses | 6.22 | 4.67 | 6.91 | 6.51 | 6.85 | 10.03 |
Total Operating Expenses | 1,956 | 2,392 | 2,537 | 2,503 | 2,463 | 2,348 |
Operating Income | 376.03 | 30.28 | 28.41 | -110.91 | 350.37 | 376.35 |
Interest Expense | -0.16 | -0.16 | -0.29 | -0.07 | -0.04 | - |
Other Non Operating Income (Expenses) | -41.82 | -41.82 | -38.19 | -59.91 | -49.43 | -46.1 |
EBT Excluding Unusual Items | 334.04 | -11.71 | -10.07 | -170.89 | 300.9 | 330.25 |
Gain (Loss) on Sale of Investments | - | - | -8.89 | - | - | - |
Gain (Loss) on Sale of Assets | 0.58 | 0.58 | - | 0.36 | 1.53 | 0.26 |
Asset Writedown | -9.46 | -9.46 | -1.37 | -9.45 | -4.44 | -0.77 |
Pretax Income | 325.16 | -20.59 | -20.33 | -179.98 | 297.99 | 329.74 |
Income Tax Expense | 36.18 | 36.18 | 36.58 | 36.58 | 64.55 | 43.04 |
Net Income | 288.98 | -56.77 | -56.91 | -216.56 | 233.43 | 286.7 |
Net Income to Common | 288.98 | -56.77 | -56.91 | -216.56 | 233.43 | 286.7 |
Net Income Growth | - | - | - | - | -18.58% | 10.11% |
Shares Outstanding (Basic) | 30 | 30 | 30 | - | 30 | 30 |
Shares Outstanding (Diluted) | 30 | 30 | 30 | - | 30 | 30 |
EPS (Basic) | 9.63 | -1.89 | -1.90 | - | 7.78 | 9.55 |
EPS (Diluted) | 9.63 | -1.89 | -1.90 | - | 7.78 | 9.55 |
EPS Growth | - | - | - | - | -18.58% | 10.11% |
Free Cash Flow | -52.59 | -453.88 | -179.45 | -362 | -175.76 | -5.87 |
Free Cash Flow Per Share | -1.75 | -15.12 | -5.98 | - | -5.86 | -0.20 |
Dividend Per Share | 1.000 | 1.000 | 1.200 | - | 1.800 | 1.274 |
Dividend Growth | -16.67% | -16.67% | - | - | 41.23% | - |
Operating Margin | 16.12% | 1.25% | 1.11% | -4.64% | 12.45% | 13.81% |
Profit Margin | 12.39% | -2.34% | -2.22% | -9.05% | 8.30% | 10.52% |
Free Cash Flow Margin | -2.25% | -18.73% | -7.00% | -15.14% | -6.25% | -0.21% |
EBITDA | 397.28 | 52.78 | 52.59 | -81.52 | 381.01 | 409.47 |
EBITDA Margin | 17.04% | 2.18% | 2.05% | -3.41% | 13.54% | 15.03% |
D&A For EBITDA | 21.25 | 22.5 | 24.18 | 29.39 | 30.64 | 33.12 |
EBIT | 376.03 | 30.28 | 28.41 | -110.91 | 350.37 | 376.35 |
EBIT Margin | 16.12% | 1.25% | 1.11% | -4.64% | 12.45% | 13.81% |
Effective Tax Rate | 11.13% | - | - | - | 21.66% | 13.05% |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.